Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation

Respirology

Volumn 22, Issue 5, 2017, Pages 928-934

  Houben Wilke, Sarah ^a   Spruit, Martijn A ^a   Uszko Lencer, Nicole H M K ^a,b   Otkinska, Gosia ^b   Vanfleteren, Lowie E G W ^a,b   Jones, Paul W ^c   Wouters, Emiel F M ^a,b   Franssen, Frits M E ^a,b  

^a CIRO+   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Chronic Obstructive Pulmonary Disease Assessment Test; Clinical Chronic Obstructive Pulmonary Disease Questionnaire; co morbidity; echocardiography; St George's Respiratory Questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL COPD QUESTIONNAIRE; CONTROLLED STUDY; COPD ASSESSMENT TEST; CROSS-SECTIONAL STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PULMONARY REHABILITATION; RESPIRATORY TRACT DISEASE ASSESSMENT; RIGHT VENTRICULAR SYSTOLIC PRESSURE; ST. GEORGE RESPIRATORY QUESTIONNAIRE; COMORBIDITY; DIAGNOSTIC IMAGING; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; QUESTIONNAIRE; RESPIRATORY CARE; VITAL CAPACITY;

AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HEART DISEASES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RESPIRATORY THERAPY; STROKE VOLUME; SURVEYS AND QUESTIONNAIRES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT; VITAL CAPACITY;

EID: 85007370282     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12968     Document Type: Article

References (40)

1. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2013; 187: 728–35.
2. Müllerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD: systematic literature review. Chest 2013; 144: 1163–78.
3. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2013; 187: 347–65.
4. Hawkins NM, Virani S, Ceconi C. Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur. Heart J. 2013; 34: 2795–803.
5. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur. Heart J. 2005; 26: 1887–94.
6. Spruit MA, Singh SJ, Garvey C, Zuwallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013; 188: e13–64.
7. Vanfleteren LE, Franssen FM, Uszko-Lencer NH, Spruit MA, Celis M, Gorgels AP, Wouters EF. Frequency and relevance of ischemic electrocardiographic findings in patients with chronic obstructive pulmonary disease. Am. J. Cardiol. 2011; 108: 1669–74.
8. Wu JR, Lennie TA, Frazier SK, Moser DK. Health-related quality of life, functional status, and cardiac event-free survival in patients with heart failure. J. Cardiovasc. Nurs. 2016; 31: 236–44.
9. Wilke S, Jones PW, Müllerova H, Vestbo J, Tal-Singer R, Franssen FME, Agusti A, Bakke P, Calverley PM, Coxson HO et al. One-year change in health status and subsequent outcomes in COPD. Thorax 2015; 70: 420–5.
10. Black-Shinn JL, Kinney GL, Wise AL, Regan EA, Make B, Krantz MJ, Barr RG, Murphy JR, Lynch D, Silverman EK et al. Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. COPD 2014; 11: 546–51.
11. Smid DE, Wilke S, Franssen FME, Jones PW, Muris JWM, Wouters EFM, Spruit MAS. Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study. BMJ Open 2015; 5: e007536.
12. Spruit MA, Pennings HJ, Janssen PP, Does JD, Scroyen S, Akkermans MA, Mostert R, Wouters EF. Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade. Respir. Med. 2007; 101: 2454–63.
13. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur. Respir. J. 2009; 34: 648–54.
14. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual. Life Outcomes 2003; 1: 13.
15. Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest 2007; 132: 456–63.
16. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 2016; 18: 891–975.
17. Rautaharju PM, Warren JW, Jain U, Wolf HK, Nielsen CL. Cardiac Infarction Injury Score: an electrocardiographic coding scheme for ischemic heart disease. Circulation 1981; 64: 249–56.
18. Freixa X, Portillo K, Pare C, Garcia-Aymerich J, Gomez FP, Benet M, Roca J, Farrero E, Ferrer J, Fernandez-Palomeque C et al. Echocardiographic abnormalities in patients with COPD at their first hospital admission. Eur. Respir. J. 2013; 41: 784–91.
19. Matamis D, Tsagourias M, Papathanasiou A, Sineffaki H, Lepida D, Galiatsou E, Nakos G. Targeting occult heart failure in intensive care unit patients with acute chronic obstructive pulmonary disease exacerbation: effect on outcome and quality of life. J. Crit. Care 2014; 29: 315.e7–14.
20. Anderson WJ, Lipworth BJ, Rekhraj S, Struthers AD, George J. Left ventricular hypertrophy in COPD without hypoxemia: the elephant in the room? Chest 2013; 143: 91–7.
21. Andersen CU, Mellemkjaer S, Nielsen-Kudsk JE, Sonderskov LD, Laursen BE, Simonsen U, Hilberg O. Echocardiographic screening for pulmonary hypertension in stable COPD out-patients and NT-proBNP as a rule-out test. COPD 2012; 9: 505–12.
22. Gologanu D, Stanescu C, Ursica T, Balea MI, Ionita D, Bogdan MA. Prevalence and characteristics of pulmonary hypertension associated with COPD - a pilot study in patients referred to a pulmonary rehabilitation program clinic. Maedica 2013; 8: 243–8.
23. O'Hare PE, Ayres JF, OʼRourke RL, Slaughter RE, Marshall HM, Bowman RV, Fong KM, Yang IA. Coronary artery calcification on computed tomography correlates with mortality in chronic obstructive pulmonary disease. J. Comput. Assist. Tomogr. 2014; 38: 753–9.
24. Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimeno G, Arakaki D, Laffaye N, Fuselli JJ, Massolin HP, Gambarte J et al. Unrecognised ventricular dysfunction in COPD. Eur. Respir. J. 2012; 39: 51–8.
25. Garcia-Rio F, Soriano JB, Miravitlles M, Munoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS One 2014; 9: e105220.
26. Wilkins JT, Ning H, Berry J, Zhao L, Dyer AR, Lloyd-Jones DM. Lifetime risk and years lived free of total cardiovascular disease. JAMA 2012; 308: 1795–801.
27. Du Q, Sun Y, Ding N, Lu L, Chen Y. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies. PLoS One 2014; 9: e113048.
28. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005; 2: 75–9.
29. Matura LA, McDonough A, Carroll DL. Health-related quality of life and psychological states in patients with pulmonary arterial hypertension. J. Cardiovasc. Nurs. 2014; 29: 178–84.
30. McDonough A, Matura LA, Carroll DL. Symptom experience of pulmonary arterial hypertension patients. Clin. Nurs. Res. 2011; 20: 120–34.
31. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler Cataluna JJ, van der Molen T, Adamek L et al. Properties of the COPD assessment test in a cross-sectional European study. Eur. Respir. J. 2011; 38: 29–35.
32. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am. Rev. Respir. Dis. 1992; 145: 1321–7.
33. Ingebrigtsen TS, Marott JL, Nordestgaard BG, Lange P, Hallas J, Vestbo J. Statin use and exacerbations in individuals with chronic obstructive pulmonary disease. Thorax 2015; 70: 33–40.
34. Carreiro A, Santos J, Rodrigues F. Impact of comorbidities in pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease. Rev. Port. Pneumol. 2013; 19: 106–13.
35. Mesquita R, Vanfleteren LEGW, Franssen FME, Sarv J, Taib Z, Groenen M, Gaffron S, Bruijnzeel PL, Pitta F, Wouters E et al. Objectively identified comorbidities in chronic obstructive pulmonary disease: impact on pulmonary rehabilitation outcomes. Eur. Respir. J. 2015; 46: 545–8.
36. Bronstad E, Tjonna AE, Rognmo O, Dalen H, Heggli AM, Wisloff U, Ingul CB, Steinshamn S. Aerobic exercise training improves right- and left ventricular systolic function in patients with COPD. COPD 2013; 10: 300–6.
37. Alter P, Luetteken L, Nell C, Haid D, Kehr K, Greulich T, Apelt S, Langenhan K, Hohmann C, Vogelmeier CF et al. Exercise training leads to physiological left ventricular hypertrophy in COPD. Int. J. Cardiol. 2014; 174: 156–7.
38. Franssen FM, Rochester CL. Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter? Eur. Respir. Rev. 2014; 23: 131–41.
39. van Mourik Y, Bertens LC, Cramer MJ, Lammers JW, Reitsma JB, Moons KG, Hoes AW, Rutten FH. Unrecognized heart failure and chronic obstructive pulmonary disease (COPD) in frail elderly detected through a near-home targeted screening strategy. J. Am. Board Fam. Med. 2014; 27: 811–21.
40. Lopez-Sanchez M, Munoz-Esquerre M, Huertas D, Gonzalez-Costello J, Ribas J, Manresa F, Dorca J, Santos S. High prevalence of left ventricle diastolic dysfunction in severe COPD associated with a low exercise capacity: a cross-sectional study. PLoS One 2013; 8: e68034.